Navigation Links
Concern From Doctors Regarding the Cardiovascular Safety of GlaxoSmithKline's Avandia Increases Nine-Fold Following Publication of Meta-Analysis
Date:4/22/2008

Nearly Three-Quarters of Physicians Have Switched Patients to Merck's

Januvia, According to a New Report from Decision Resources

WALTHAM, Mass., April 22 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the percentage of primary care physicians (PCPs) and endocrinologists who consider the cardiovascular safety of GlaxoSmithKline's Avandia to be a major concern increased more than nine-fold following publication of a meta-analysis. Published in May 2007 by Steve Nissen in the New England Journal of Medicine, the meta-analysis calls into question the cardiovascular safety of Avandia and features analysis of data from several different trials showing that the drug increases the risk of myocardial infarction by 43 percent. Prescriptions for Avandia dropped significantly in the weeks following publication of the meta-analysis. According to the new Physician and Payer Forum report entitled Avandia One Year Later-A Physician and Payer Perspective, the full impact of the meta-analysis on Avandia prescribing has not yet been felt. 58 percent of PCPs and 52 percent of endocrinologists say they will reduce their prescribing of Avandia over the next year.

The report also finds that nearly three-quarters of physicians say they have switched patients to Merck's Januvia as a result of the Avandia meta-analysis. More than 80 percent of surveyed physicians say they will increase the number of total prescriptions they write for Januvia over the next two years. Although clinicians and managed care organizations surveyed consider metformin (Bristol-Myers Squibb's Glucophage, generics) to offer the best overall safety and efficacy, Januvia received the second greatest number of votes for "agent with the best overall safety profile" and for "lowest risk of hypoglycemia." In comparison, Amylin/Eli Lilly's Byetta was chosen by endocrinologists and MCOs as the agent
'/>"/>

SOURCE Decision Resources
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Wal-Mart & Nalgene Removing Toxic Bottles, Place Consumers Concerns First
2. 18th Annual Retirement Confidence Survey:(R) Workers Show Record Drop in Retirement Confidence, Health Care and Economy Are Major Concerns
3. Operating Room Nurses are Concerned about Complications Associated with Powdered Gloves
4. Genaera Corporation Receives Audit Opinion Containing Going Concern Explanatory Paragraph
5. Iomai Reports Going Concern Qualification in 10-K
6. CryoCor Reports Going Concern Statement and Receives Notification From Nasdaq Relating to Minimum Stockholders Equity
7. Talent Shortage Emerges as No. 1 Employer Concern: Deloitte/ISCEBS
8. National Religious Coalition Deeply Concerned by HHS Secretarys Disregard for Womens Reproductive Health
9. Project Concern International Receives a US$1 Million Grant From the Starbucks Foundations Ethos Water Fund to Provide Safe Water and Sanitation Services in Tanzania
10. Bi-Partisan Members of United States Senate Formally Raise Concerns About Proposed Cuts to Medicares Home Oxygen Benefit
11. TransUnion Addresses Ohio Attorney Generals Concerns Surrounding Non-Profit Tax-Exempt Status

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)..., SBA Provision, Antitrust Language, Federal T...n Senate ,, WASHINGTON, Nov. 9 /PRNewswire-USN...able Health Care for America Act (H.R. 3962) allow...ed by health insurance exchanges is positive, but ... according to the National Association of Professi...
(Date:11/9/2009)...tudy in mice reports success with drugs that inhib...Day News) -- Two drugs used to treat breast cancer...ce, according to a new study. , The drugs also ...ina, and prevented the onset of cancer in mice wit...g fulvestrant and the breast cancer/osteoporosis d...
(Date:11/9/2009)... Networking is everybody,s...t means Money. StaffingClub.com enables Recruiters...contacts to connect, share, communicate and close ...ekers to post their profiles and network with recr...r 9, 2009 -- Current Job Market forces everyone to...
(Date:11/9/2009)...abbits implanted with new cells regained sexual fu...9 (HealthDay News) -- Researchers were able to res...es by growing new penile tissue in the lab and imp...an application is a ways off, researchers say the ...ectile dysfunction in men. , "We were able to s...
(Date:11/9/2009)... Tomorrow may be too late ...s condition, according to TOPS Club, Inc. (Take Of...ort organization. , (Vocu...en it comes to preventing or improving a diabetes ...Pounds Sensibly), the nonprofit weight-loss suppor...
Breaking Medicine News(10 mins):Health News:PIA Says Inclusion of Agents in House Healthcare Bill is Positive, But Concerns Remain 2Health News:PIA Says Inclusion of Agents in House Healthcare Bill is Positive, But Concerns Remain 3Health News:Breast Cancer Drugs May Fight Cervical Cancer, Too 2Health News:Launching StaffingClub.com, a New Online Networking Platform for Recruiting and Staffing Professionals 2Health News:Scientists Grow New Penile Tissue in the Lab 2Health News:Scientists Grow New Penile Tissue in the Lab 3Health News:Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says 2Health News:Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says 3
...at wrestler Benoits' 7-year-old son, Daniel, was s... level of the anti-anxiety drug Xanax was found i...ad a steroid and other drugs in his system when he...the Georgia Bureau of Investigation, released the ...
...t in the July issue of Archives of Surgery,Individ...e intensive care unit , use more ventilator suppor...on for trauma than non-diabetics. Approximat...op complications more frequently and do worse afte...
...(AHS) is a rare neurological disorder that causes ...at is happening or having control over the action ...r objects and manipulate them without wanting to d...n both voluntary and involuntary movement and foun...
...t in the July issue of Archives of Surgery,the rat...by the bacteria Clostridium difficile more than d...tates between 1993 and 2003, and the illness was m...y adults and about 20 percent of patients receivin...
... by a researcher from Saint Louis University Schoo...and depression - genetics . Qiang John Fu,...hat the that a persons genes, that are also associ...nt. Dr. Fu and his team analyzed 3,360 pai...
...cutaneous T-cell lymphoma became substantially mor...2 , according to a report in the July issue of Arc...y by race, sex and geographic area. Cutaneous...pes of lymphoma, according to background informati...
Other Medicine News:Health News:Wrestler Chris Benoits Son was Sedated - Says Investigators 2Health News:Diabetes may Lead to More Complications 2Health News:Alien Hand Syndrome Causes Random Hand Movement 2Health News:Colitis More Common in Hospitalized Patients 2Health News:Colitis More Common in Hospitalized Patients 3Health News:Colitis More Common in Hospitalized Patients 4Health News:Study Finds Genetic Link Between Smoking Addiction and Major Depression 2Health News:Cutaneous T-cell Lymphoma Shows Steady Increase 2
(Date:11/9/2009)...-- TessArae® LLC, a global leader in resequen...launch of new integrated product solutions for gen...hereditary diseases. The combination of TessArae,...novel nucleotide sequence basecalling algorithms a...geted mutations in multiple genes of a syndrome or...
(Date:11/9/2009)...tCall/ -- Monsanto Company (NYSE: MON ) and Pfize... entered into an agreement for Monsanto to acquire...ated in Chesterfield, Mo. Under the terms of the ... Pfizer for $435 million to be paid over time, and...rfield Village through a lease agreement, primaril...
(Date:11/9/2009)...all/ -- Boston Scientific Corporation (NYSE: BSX ...ardiac resynchronization therapy defibrillator (CR...fibrillator (ICD) in Japan. These devices were ap...nd Welfare (MHLW) in August and received reimburse...e the result of a multi-year research and developm...
Breaking Medicine Technology:TessArae Delivers Lower Cost Option to Genetic Testing Market 2Monsanto to Purchase Chesterfield Village Research Center From Pfizer 2Monsanto to Purchase Chesterfield Village Research Center From Pfizer 3Boston Scientific's Most Advanced Devices to Treat Heart Failure and Sudden Cardiac Death Now Available in Japan 2Boston Scientific's Most Advanced Devices to Treat Heart Failure and Sudden Cardiac Death Now Available in Japan 3Boston Scientific's Most Advanced Devices to Treat Heart Failure and Sudden Cardiac Death Now Available in Japan 4K State Veterinarian Says Owners Should Count How Many Calories Their Obese Pets Take In And Consider Several Factors When Feeding Pets For Good Healt 59110 1K State Veterinarian Says Owners Should Count How Many Calories Their Obese Pets Take In And Consider Several Factors When Feeding Pets For Good Healt 59110 2K State Veterinarian Says Owners Should Count How Many Calories Their Obese Pets Take In And Consider Several Factors When Feeding Pets For Good Healt 59110 3Statewide Drug Card Program Launching 59108 1Roche Scientist Recognized for Excellence in Peptide Chemistry 5312 1Roche Scientist Recognized for Excellence in Peptide Chemistry 5312 2Roche Scientist Recognized for Excellence in Peptide Chemistry 5312 3Roche Scientist Recognized for Excellence in Peptide Chemistry 5312 4
...erapeutic Strategy for ...BioSciences, Inc. (Nasdaq: SGMO ) announced today...immune system cells (CD4 T-cells) can be made,resi...er DNA-binding,protein nucleases (ZFN(TM)). The da... the permanent modification of the CCR5 gene encod...
...U clinical trials in the, United States and abund... CHARLOTTE, N.C., June 27 USHIFU, LLC, the exclu...te(R) 500 for prostate cancer,treatment in North a...,edition of ABC News NIGHTLINE featured a segment ...eating prostate cancer outside of the United State...
Other Medicine Technology:Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Generate HIV Resistant T Cells 2Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Generate HIV Resistant T Cells 3Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Generate HIV Resistant T Cells 4Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Generate HIV Resistant T Cells 5Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Generate HIV Resistant T Cells 6ABC News NIGHTLINE Features HIFU with Sonablate(R) 500 as Non Invasive Treatment Option for Prostate Cancer 2ABC News NIGHTLINE Features HIFU with Sonablate(R) 500 as Non Invasive Treatment Option for Prostate Cancer 3
...mechanism for speed, stability and durability. Bac...og display modes, multiple units of measure, piece...t, and GLP/GMP/ISO output including date and time ...internal calibration mass for convenient Touch-key...
...mechanism for speed, stability and durability. Bac...og display modes, multiple units of measure, piece...t, and GLP/GMP/ISO output including date and time ...th external weights only (selectable range). Shima...
Thermometer
Digital Thermometer & High-Low Temp Alarm
Medicine Products: